Endogenous Sex Steroid Levels and Cardiovascular Disease in Relation to the Menopause: A Systematic Review

Endocrinology and Metabolism Clinics of North America

Volumn 42, Issue 2, 2013, Pages 227-253

  Crandall, Carolyn J ^a   Barrett Connor, Elizabeth ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coronary artery disease; Coronary heart disease; Endogenous estrogen; Estradiol; Hormone therapy; Menopause; Sex hormone binding globulin

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLACEBO; PROGESTERONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

AGING; ANGIOCARDIOGRAPHY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; EARLY INTERVENTION; ESTROGEN BLOOD LEVEL; HEART FAILURE; HEART INFARCTION; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; ISCHEMIC HEART DISEASE; MENOPAUSE; OVARIECTOMY; OVARY FUNCTION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SEX DIFFERENCE; SYSTEMATIC REVIEW; UNITED STATES;

AGING; ANDROGENS; CARDIOVASCULAR DISEASES; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERLIPIDEMIAS; POSTMENOPAUSE; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN;

EID: 84878145830     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2013.02.003     Document Type: Review

References (66)

1. Kochanek K., Xu J., Murphy S., et al. Deaths: final data for 2009 2012, National Center for Health Statistics, Hyattsville (MD).
2. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125(1):e2-e220.
3. Saltiki K., Doukas C., Kanakakis J., et al. Severity of cardiovascular disease in women: relation with exposure to endogenous estrogen. Maturitas 2006, 55(1):51-57.
4. de Kleijn M.J., van der Schouw Y.T., Verbeek A.L., et al. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol 2002, 155(4):339-345.
5. Wellons M., Ouyang P., Schreiner P.J., et al. Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis. Menopause 2012, 19(10):1081-1087.
6. Hu F.B., Grodstein F., Hennekens C.H., et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999, 159(10):1061-1066.
7. Tremollieres F.A., Pouilles J.M., Cauneille C., et al. Coronary heart disease risk factors and menopause: a study in 1684 French women. Atherosclerosis 1999, 142(2):415-423.
8. de Aloysio D., Gambacciani M., Meschia M., et al. The effect of menopause on blood lipid and lipoprotein levels. The Icarus Study Group. Atherosclerosis 1999, 147(1):147-153.
9. Sultan N., Nawaz M., Sultan A., et al. Effect of menopause on serum HDL-cholesterol level. J Ayub Med Coll Abbottabad 2003, 15(3):24-26.
10. Matthews K.A., Crawford S.L., Chae C.U., et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?. J Am Coll Cardiol 2009, 54(25):2366-2373.
11. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1995, 273(3):199-208.
12. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998, 280(7):605-613.
13. Manson J.E., Hsia J., Johnson K.C., et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003, 349(6):523-534.
14. Toh S., Hernandez-Diaz S., Logan R., et al. Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial. Ann Intern Med 2010, 152(4):211-217.
15. Rossouw J.E., Prentice R.L., Manson J.E., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007, 297(13):1465-1477.
16. Hsia J., Langer R.D., Manson J.E., et al. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 2006, 166(3):357-365.
17. Manson J.E., Allison M.A., Rossouw J.E., et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007, 356(25):2591-2602.
18. Schierbeck L.L., Rejnmark L., Tofteng C.L., et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 2012, 345:e6409.
19. Kronos Longevity Research Institute. Hormone therapy has many favorable effects in newly menopausal women: initial findings of the Kronos Early Estrogen Prevention study (KEEPS). 2012. Available at:. Accessed November 8, 2012. http://www.keepstudy.org/news/pr_100312_a.pdf.
20. Harman S.M., Brinton E.A., Cedars M., et al. KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric 2005, 8(1):3-12.
21. Farish E., Rolton H.A., Barnes J.F., et al. Lipoprotein(a) and postmenopausal oestrogen. Acta Endocrinol (Copenh) 1993, 129(3):225-228.
22. Davison S., Davis S.R. New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 2003, 88(6):2470-2478.
23. Manson J.E., Bassuk S.S. Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?. Am J Epidemiol 2007, 166(5):511-517.
24. Barrett-Connor E. Hormones and heart disease in women: the timing hypothesis. Am J Epidemiol 2007, 166(5):506-510.
25. Khatibi A., Agardh C.D., Shakir Y.A., et al. Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: the Women's Health in the Lund Area (WHILA) Study. Climacteric 2007, 10(5):386-392.
26. Barrett-Connor E., Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ 1995, 311(7014):1193-1196.
27. Goodman-Gruen D., Barrett-Connor E. A prospective study of sex hormone-binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women. J Clin Endocrinol Metab 1996, 81(8):2999-3003.
28. Page-Wilson G., Goulart A.C., Rexrode K.M. Interrelation between sex hormones and plasma sex hormone-binding globulin and hemoglobin A1c in healthy postmenopausal women. Metab Syndr Relat Disord 2009, 7(3):249-254.
29. Braunstein G.D., Johnson B.D., Stanczyk F.Z., et al. Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease. J Clin Endocrinol Metab 2008, 93(11):4268-4275.
30. Cauley J.A., Gutai J.P., Glynn N.W., et al. Serum estrone concentrations and coronary artery disease in postmenopausal women. Arterioscler Thromb 1994, 14(1):14-18.
31. Chen Y., Zeleniuch-Jacquotte A., Arslan A.A., et al. Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis 2011, 216(2):414-419.
32. Jeon G.H., Kim S.H., Yun S.C., et al. Association between serum estradiol level and coronary artery calcification in postmenopausal women. Menopause 2010, 17(5):902-907.
33. Munir J.A., Wu H., Bauer K., et al. The perimenopausal atherosclerosis transition: relationships between calcified and noncalcified coronary, aortic, and carotid atherosclerosis and risk factors and hormone levels. Menopause 2012, 19(1):10-15.
34. Naessen T., Sjogren U., Bergquist J., et al. Endogenous steroids measured by high-specificity liquid chromatography-tandem mass spectrometry and prevalent cardiovascular disease in 70-year-old men and women. J Clin Endocrinol Metab 2010, 95(4):1889-1897.
35. Ouyang P., Vaidya D., Dobs A., et al. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2009, 204(1):255-261.
36. Patel S.M., Ratcliffe S.J., Reilly M.P., et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2009, 94(12):4776-4784.
37. Rexrode K.M., Manson J.E., Lee I.M., et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003, 108(14):1688-1693.
38. Phillips G.B., Pinkernell B.H., Jing T.Y. Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol 1997, 17(4):695-701.
39. Shakir Y.A., Samsioe G., Khatibi E.A., et al. Health hazards in middle-aged women with cardiovascular disease: a case-control study of Swedish women. The women's health in the Lund area (WHILA) study. J Womens Health (Larchmt) 2007, 16(3):406-414.
40. Skalba P., Wojtowicz M., Sikora J. Androgen and SHBG serum concentrations in late post-menopause women. Med Sci Monit 2003, 9(3):CR152-CR156.
41. Calderon-Margalit R., Schwartz S.M., Wellons M.F., et al. Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: the "Coronary Artery Risk Development in Young Adults" women's study. J Clin Endocrinol Metab 2010, 95(9):4424-4431.
42. Lapidus L., Lindstedt G., Lundberg P.A., et al. Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women. Clin Chem 1986, 32(1 Pt 1):146-152.
43. Laughlin G.A., Goodell V., Barrett-Connor E. Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. J Clin Endocrinol Metab 2010, 95(2):740-747.
44. Sievers C., Klotsche J., Pieper L., et al. Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients. Eur J Endocrinol 2010, 163(4):699-708.
45. Goodman-Gruen D., Barrett-Connor E. Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 2000, 23(7):912-918.
46. Haffner S.M., Newcomb P.A., Marcus P.M., et al. Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women. Am J Epidemiol 1995, 142(9):925-934.
47. Kalish G.M., Barrett-Connor E., Laughlin G.A., et al. Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab 2003, 88(4):1646-1652.
48. Lambrinoudaki I., Christodoulakos G., Rizos D., et al. Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women. Eur J Endocrinol 2006, 154(6):907-916.
49. Masi C.M., Hawkley L.C., Xu X., et al. Serum estrogen metabolites and systolic blood pressure among middle-aged and older women and men. Am J Hypertens 2009, 22(11):1148-1153.
50. Mesch V.R., Siseles N.O., Maidana P.N., et al. Androgens in relationship to cardiovascular risk factors in the menopausal transition. Climacteric 2008, 11(6):509-517.
51. Mudali S., Dobs A.S., Ding J., et al. Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J Clin Endocrinol Metab 2005, 90(2):1202-1209.
52. Phillips G.B., Jing T.Y., Laragh J.H. Serum sex hormone levels in postmenopausal women with hypertension. J Hum Hypertens 1997, 11(8):523-526.
53. Shelley J.M., Green A., Smith A.M., et al. Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. Ann Epidemiol 1998, 8(1):39-45.
54. Tufano A., Marzo P., Enrini R., et al. Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause. J Endocrinol Invest 2004, 27(7):648-653.
55. Oh J.Y., Barrett-Connor E., Wedick N.M., et al. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 2002, 25(1):55-60.
56. Ding E.L., Song Y., Manson J.E., et al. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia 2007, 50(10):2076-2084.
57. Janssen I., Powell L.H., Crawford S., et al. Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch Intern Med 2008, 168(14):1568-1575.
58. Kalyani R.R., Franco M., Dobs A.S., et al. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab 2009, 94(11):4127-4135.
59. Vitale C., Fini M., Speziale G., et al. Gender differences in the cardiovascular effects of sex hormones. Fundam Clin Pharmacol 2010, 24(6):675-685.
60. Vitale C., Mercuro G., Cerquetani E., et al. Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol 2008, 28(2):348-352.
61. Li X.P., Zhou Y., Zhao S.P., et al. Effect of endogenous estrogen on endothelial function in women with coronary heart disease and its mechanism. Clin Chim Acta 2004, 339(1-2):183-188.
62. Qiao X., McConnell K.R., Khalil R.A. Sex steroids and vascular responses in hypertension and aging. Gend Med 2008, 5(Suppl A):S46-S64.
63. Peter I., Kelley-Hedgepeth A., Fox C.S., et al. Variation in estrogen-related genes associated with cardiovascular phenotypes and circulating estradiol, testosterone, and dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 2008, 93(7):2779-2785.
64. Demissie S., Cupples L.A., Shearman A.M., et al. Estrogen receptor-alpha variants are associated with lipoprotein size distribution and particle levels in women: the Framingham Heart Study. Atherosclerosis 2006, 185(1):210-218.
65. Post W.S., Goldschmidt-Clermont P.J., Wilhide C.C., et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999, 43(4):985-991.
66. Vaidya D., Becker D.M., Bittner V., et al. Ageing, menopause, and ischaemic heart disease mortality in England, Wales, and the United States: modelling study of national mortality data. BMJ 2011, 343:d5170.